TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway

被引：0
|
作者：
Ying Xing
Yuechao Liu
Tianbo Liu
Qingwei Meng
Hailing Lu
Wei Liu
Jing Hu
Chunhong Li
Mengru Cao
Shi Yan
Jian Huang
Ting Wang
Li Cai
机构：
[1] Harbin Medical University Cancer Hospital,The Fourth Department of Medical Oncology
[2] Harbin Medical University Cancer Hospital,Department of Gynecology
[3] Harbin Medical University,The Sixth Department of Medical Oncology
[4] Harbin Medical University Cancer Hospital,undefined
来源：
Cell Communication and Signaling | / 16卷
关键词：
TNFAIP8; NSCLC; Proliferation; Cisplatin chemoresistance; MDM2/p53 pathway;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] DDIAS promotes invasion and proliferation of non-small cell lung cancer and predicts poor survival of lung cancer patients
    Liu, Nan
    Zhang, Xiupeng
    Zhou, Haijing
    Cai, Lin
    Li, Ailin
    Miao, Yuan
    Li, Qingchang
    Qiu, Xueshan
    Wang, Enhua
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (12): : 11506 - 11515
  • [42] PAQR4 promotes chemoresistance in non-small cell lung cancer through inhibiting Nrf2 protein degradation
    Xu, Peifang
    Jiang, Liping
    Yang, Yang
    Wu, Mengge
    Liu, Baiyang
    Shi, Yulin
    Shen, Qiushuo
    Jiang, Xiulin
    He, Yaomei
    Cheng, Dating
    Xiong, Qiuxia
    Yang, Zuozhang
    Duan, Lincan
    Lin, Jie
    Zhao, Song
    Shi, Peng
    Yang, Cuiping
    Chen, Yongbin
    THERANOSTICS, 2020, 10 (08): : 3767 - 3778
  • [43] p53 status and prognosis in stage I-IIIa non-small cell lung cancer
    Ohno, A
    Hirashima, T
    Kubo, A
    Masuda, N
    Takada, M
    Fujiwara, H
    Yasumitsu, T
    Kikui, M
    Fukuoka, M
    Nakagawa, K
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1997, 10 (03) : 521 - 528
  • [44] tRF-Leu-CAG promotes cell proliferation and cell cycle in non-small cell lung cancer
    Shao, Yang
    Sun, Qiangling
    Liu, Xiaomin
    Wang, Ping
    Wu, Renqi
    Ma, Zhongliang
    CHEMICAL BIOLOGY & DRUG DESIGN, 2017, 90 (05) : 730 - 738
  • [45] The clinical relevance of Bcl-2, Rb and p53 expression in advanced non-small cell lung cancer
    Gregorc, V
    Darwish, S
    Ludovini, V
    Pistola, L
    De Angelis, V
    Mihaylova, Z
    Bellezza, G
    Sidoni, A
    Cavaliere, A
    Bucciarelli, E
    Massaro, G
    Tonato, M
    LUNG CANCER, 2003, 42 (03) : 275 - 281
  • [46] HUWE1 controls the development of non-small cell lung cancer through down-regulation of p53
    Yang, Dong
    Cheng, Daomei
    Tu, Qiu
    Yang, Huihui
    Sun, Bin
    Yan, Lanzhen
    Dai, Hongjuan
    Luo, Jierong
    Mao, Bingyu
    Cao, Yi
    Yu, Xiaoping
    Jiang, Hua
    Zhao, Xudong
    THERANOSTICS, 2018, 8 (13): : 3517 - 3529
  • [47] circRACGAP1 Promotes Proliferation of Non-Small Cell Lung Cancer Cells through the miR-1296/CDK2 Pathway
    Zhao, Yang
    Deng, Liyong
    Xie, Yi
    Wang, Weiming
    Chai, Qin
    Wang, Guihua
    FOLIA BIOLOGICA, 2024, 70 (02) : 104 - 112
  • [48] Silencing of lncRNA XIST inhibits non-small cell lung cancer growth and promotes chemosensitivity to cisplatin
    Xu, Xiaohui
    Zhou, Xiaoyun
    Chen, Zhenju
    Gao, Chao
    Zhao, Luo
    Cui, Yushang
    AGING-US, 2020, 12 (06): : 4711 - 4726
  • [49] MDM2 gene amplification:: a new independent factor of adverse prognosis in non-small cell lung cancer (NSCLC)
    Dworakowska, D
    Jassem, E
    Jassem, J
    Peters, B
    Dziadziuszko, R
    Zylicz, M
    Jakóbkiewicz-Banecka, J
    Kobierska-Gulida, G
    Szymanowska, A
    Skokowski, J
    Roessner, A
    Schneider-Stock, R
    LUNG CANCER, 2004, 43 (03) : 285 - 295
  • [50] Unlocking the potential of LHPP: Inhibiting glioma growth and cell cycle via the MDM2/p53 pathway
    Guo, Lili
    Chen, Wenjin
    Yue, Jiong
    Gao, Mingjun
    Zhang, Jin
    Huang, Yukai
    Xiong, Huan
    Li, Xinda
    Wang, Yangyang
    Yuan, Ying
    Chen, Longyi
    Fei, Fan
    Xu, Ruxiang
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2025, 1871 (01):
12345